Dynamic Plasma KRAS ctDNA Profiling Identifies Treatment Response and Nascent Resistance in Metastatic Non-Small-Cell Lung Cancer: A Pilot Study
Simple Summary Mutations in the KRAS gene are common in metastatic lung cancer and may influence how the disease behaves and responds to treatment. In this study, we compared KRAS mutations detected in tumor tissue with those found in blood samples using circulating tumor DNA (ctDNA), a minimally invasive “liquid biops...